Effectiveness of a Four-Session Focal Shock Wave Therapy Protocol in Women With Vulvodynia
Recruiting
Observational Study
Vulvodynia
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 and older
- Sex
- Female
- Study type
- Observational
- Participants needed
- 50 (estimated)
- Sponsor
- Nantes University Hospital · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Vulvodynia is a chronic vulvar pain condition that can significantly affect quality of life. Low-intensity focal extracorporeal shock wave therapy has been proposed as a non-invasive therapeutic option, but real-world data remain limited.
This retrospective observational study aims to evaluate the effectiveness of a four-session focal shock wave therapy protocol in women with vulvodynia treated i…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Female patients aged 18 years or older
* Clinical diagnosis of vulvodynia
* Received at least one session of low-intensity focal extracorporeal shock wave therapy in routine clinical practice
Exclusion Criteria:
* Refusal to participate (non-opposition not obtained)
* Inabil…
Contacts